Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance

Abstract The objective of this study is to examine the IgG antibody response in critically ill patients with the Middle East respiratory syndrome (MERS) and to examine the association of early antibody response with mortality and viral clearance. We collected blood samples from 40 consecutive real-t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yaseen M Arabi, Ali H. Hajeer, Hanan Balkhy, Sameera Al Johani, Musharaf Sadat, Abdulaziz Al-Dawood, Alanoud Abu Taleb, Jesna Jose, Eman Al Qasim, Abdulaziz Al Ajlan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/31ebb17872554cefac52f3953e1ff156
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:31ebb17872554cefac52f3953e1ff156
record_format dspace
spelling oai:doaj.org-article:31ebb17872554cefac52f3953e1ff1562021-11-21T12:17:20ZKinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance10.1038/s41598-021-01083-y2045-2322https://doaj.org/article/31ebb17872554cefac52f3953e1ff1562021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01083-yhttps://doaj.org/toc/2045-2322Abstract The objective of this study is to examine the IgG antibody response in critically ill patients with the Middle East respiratory syndrome (MERS) and to examine the association of early antibody response with mortality and viral clearance. We collected blood samples from 40 consecutive real-time reverse transcription-polymerase chain reaction (rRT-PCR) confirmed critically ill MERS patients on ICU days 1, 3, 7, 14 and 28. MERS-CoV antibodies were detected by enzyme-linked immunosorbent assay (ELISA), using wells coated with MERS-CoV S1 antigen. Patients were admitted to ICU after a median (Q1, Q3) of 9 (4, 13) days from onset of symptoms with an admission Sequential Organ Failure Assessment (SOFA) score of 11 (6.5, 12). Among the study cohort, 38 patients (95%) received invasive ventilation, 35 (88%) vasopressors, 21 (53%) renal replacement therapy and 17 (43%) corticosteroids. Median (Q1,Q3) ELISA optical density (OD) ratio significantly increased with time (p < 0.001) from 0.11 (0.07, 1.43) on day 1; to 0.69 (0.11, 2.08) on day 3, 2.72 (1.84, 3.54) on day 7, 2.51 (0.35, 3.35) on day 14 and 3.77 (3.70, 3.84) on day 28. Early antibody response (day 1–3) was observed in 13/39 patients (33%) and was associated with lower mortality (hazard ratio: 0.31, 95% CI 0.10, 0.96, p = 0.04) but was not associated with faster clearance of MERS-CoV RNA. In conclusion, among critically ill patients with MERS, early antibody response was associated with lower mortality but not with faster clearance of MERS-CoV RNA. These findings have important implications for understanding pathogenesis and potential immunotherapy.Yaseen M ArabiAli H. HajeerHanan BalkhySameera Al JohaniMusharaf SadatAbdulaziz Al-DawoodAlanoud Abu TalebJesna JoseEman Al QasimAbdulaziz Al AjlanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yaseen M Arabi
Ali H. Hajeer
Hanan Balkhy
Sameera Al Johani
Musharaf Sadat
Abdulaziz Al-Dawood
Alanoud Abu Taleb
Jesna Jose
Eman Al Qasim
Abdulaziz Al Ajlan
Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance
description Abstract The objective of this study is to examine the IgG antibody response in critically ill patients with the Middle East respiratory syndrome (MERS) and to examine the association of early antibody response with mortality and viral clearance. We collected blood samples from 40 consecutive real-time reverse transcription-polymerase chain reaction (rRT-PCR) confirmed critically ill MERS patients on ICU days 1, 3, 7, 14 and 28. MERS-CoV antibodies were detected by enzyme-linked immunosorbent assay (ELISA), using wells coated with MERS-CoV S1 antigen. Patients were admitted to ICU after a median (Q1, Q3) of 9 (4, 13) days from onset of symptoms with an admission Sequential Organ Failure Assessment (SOFA) score of 11 (6.5, 12). Among the study cohort, 38 patients (95%) received invasive ventilation, 35 (88%) vasopressors, 21 (53%) renal replacement therapy and 17 (43%) corticosteroids. Median (Q1,Q3) ELISA optical density (OD) ratio significantly increased with time (p < 0.001) from 0.11 (0.07, 1.43) on day 1; to 0.69 (0.11, 2.08) on day 3, 2.72 (1.84, 3.54) on day 7, 2.51 (0.35, 3.35) on day 14 and 3.77 (3.70, 3.84) on day 28. Early antibody response (day 1–3) was observed in 13/39 patients (33%) and was associated with lower mortality (hazard ratio: 0.31, 95% CI 0.10, 0.96, p = 0.04) but was not associated with faster clearance of MERS-CoV RNA. In conclusion, among critically ill patients with MERS, early antibody response was associated with lower mortality but not with faster clearance of MERS-CoV RNA. These findings have important implications for understanding pathogenesis and potential immunotherapy.
format article
author Yaseen M Arabi
Ali H. Hajeer
Hanan Balkhy
Sameera Al Johani
Musharaf Sadat
Abdulaziz Al-Dawood
Alanoud Abu Taleb
Jesna Jose
Eman Al Qasim
Abdulaziz Al Ajlan
author_facet Yaseen M Arabi
Ali H. Hajeer
Hanan Balkhy
Sameera Al Johani
Musharaf Sadat
Abdulaziz Al-Dawood
Alanoud Abu Taleb
Jesna Jose
Eman Al Qasim
Abdulaziz Al Ajlan
author_sort Yaseen M Arabi
title Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance
title_short Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance
title_full Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance
title_fullStr Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance
title_full_unstemmed Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance
title_sort kinetics of antibody response in critically ill patients with middle east respiratory syndrome and association with mortality and viral clearance
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/31ebb17872554cefac52f3953e1ff156
work_keys_str_mv AT yaseenmarabi kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT alihhajeer kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT hananbalkhy kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT sameeraaljohani kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT musharafsadat kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT abdulazizaldawood kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT alanoudabutaleb kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT jesnajose kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT emanalqasim kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
AT abdulazizalajlan kineticsofantibodyresponseincriticallyillpatientswithmiddleeastrespiratorysyndromeandassociationwithmortalityandviralclearance
_version_ 1718419055039217664